|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ABSORPTION
|
ANTACIDS CAN DELAY & DECREASE ORAL ABSOPTION, AVOID MEDICINES WITHIN 2 HRS OF ANTACIDS
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
BACTERIOSTATICS LIKE TETRACYCLINES MAY INTERFERE WITH BACTERICIDAL EFFECTS OF PENICILLIN ; THIS HAS BEEN DEMONSTRATED IN VITRO, HOWEVER, THE CLINICAL SIGNIFICANCE OF THE INTERACTION IS NOT WELL DOCUMENTED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
HYPOGLYCEMIC EFFECT IS POTENTIATED
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
IRON SALTS INTERFERE WITH THE ABSORPTION OF THE DRUG: HENCE IT SHOULD BE ADMINISTERED 4 HRS BEFORE IRON CONTAINING SALTS
|
CO-ADMINISTRATION HAS RESULTED IN INCREASED PROTHROMBIN TIME, WITH OR WITHOUT CLINICAL BLEEDING
|
|
|
|
|
|
|
|
|
|
APROTININ IS INCOMPATIBLE WITH THE DRUG
|
ZINC WHEN CONCURRENTLY ADMINISTERED CAN IMPAIRE ABSORPTION OF THE OTHER DRUG, SO ZINC SHOULD BE GIVEN 6 HRS BEFORE OR 2 HRS AFTER THE OTHER DRUG
|
ZINC WHEN CONCURRENTLY ADMINISTERED CAN IMPAIRE ABSORPTION OF THE OTHER DRUG, SO ZINC SHOULD BE GIVEN 6 HRS BEFORE OR 2 HRS AFTER THE OTHER DRUG
|
ZINC WHEN CONCURRENTLY ADMINISTERED CAN IMPAIRE ABSORPTION OF THE OTHER DRUG, SO ZINC SHOULD BE GIVEN 6 HRS BEFORE OR 2 HRS AFTER THE OTHER DRUG
|
ZINC WHEN CONCURRENTLY ADMINISTERED CAN IMPAIRE ABSORPTION OF THE OTHER DRUG, SO ZINC SHOULD BE GIVEN 6 HRS BEFORE OR 2 HRS AFTER THE OTHER DRUG
|
ZINC WHEN CONCURRENTLY ADMINISTERED CAN IMPAIRE ABSORPTION OF THE OTHER DRUG, SO ZINC SHOULD BE GIVEN 6 HRS BEFORE OR 2 HRS AFTER THE OTHER DRUG
|
MOLYBDENUM IMPAIRES THE ABSORPTION OF THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
INSULIN REQUIREMENT IS DECREASED BY THE DRUG
|
CO-ADMINISTRATION WITH ANTIPLATELET AGENTS MAY BE ASSOCIATED WITH AN INCREASE IN BLEEDING.
|
CO-ADMINISTRATION WITH ANTIPLATELET AGENTS MAY BE ASSOCIATED WITH AN INCREASE IN BLEEDING.
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
ANTICOAGULANT EFFECT IS INCREASED OF ORAL ANTICOAGULANTS
|
POTENTIAL FOR INCREASED MYELOTOXICITY AND NEPHROTOXICITY
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|
ASPIRIN MAY ANTAGONISE THE EFFECTS OF TETRACYCLINES
|